Clinical Trials Directory

Trials / Unknown

UnknownNCT03695354

Impact of Whole-body Vibration Training on Sarcopenic Elderly

Impact of Whole-body Vibration Training on Sarcopenia in Geriatric Hospitalized Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

Sarcopenia is defined as a phenomenon which the amount of muscle mass in elderly aged 60-70 years is about 20-30% lower than that of the young adults and middle-aged people due to muscle atrophy caused by aging and alteration in muscle itself in aged skeletal muscle. Whole body vibration(WBV) training can be a choice for hospitalized patients who cannot conduct high intensity resistance training.

Detailed description

This study is prospective study. The goal of this study is 1. To investigate the effect of whole body vibration training using vibration platform with tilt table on muscle mass, muscle strength, physical performance in hospitalized older adults with sarcopenia. 2. To demonstrate whether whole body vibration training using vibration platform with tilt table can be useful in hospitalized older adults with sarcopenia who could not perform high intensity exercise.

Conditions

Interventions

TypeNameDescription
DEVICEwhole body vibration plus conventional therapySubjects enrolled in whole body vibration training group are exposed to side-to-side alternating vertical sinusoidal vibration. Galileo system(Novotec Medical GmbH, Pforzheim, Germany) is used to training. Frequency of whole body vibration is 12Hz and amplitude is 4mm. After 10 minutes of vibration training, subjects rest 3 minutes. Then, additional 10 minutes of training will be given. conventional physical therapy is consisted of passive range of motion exercise and walking exercise.
PROCEDUREconventional therapyconventional physical therapy is consisted of passive range of motion exercise and walking exercise.

Timeline

Start date
2017-02-08
Primary completion
2021-05-31
Completion
2021-07-31
First posted
2018-10-04
Last updated
2021-01-15

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03695354. Inclusion in this directory is not an endorsement.